Lisa M Southern, LMLP, LCP Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 1145 E Kansas Plz, Garden City, KS 67846 Phone: 620-275-0625 Fax: 620-275-7908 |
Max E Meschberger, LMLP, LCP, LCMFT Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 1145 E Kansas Plz, Garden City, KS 67846 Phone: 620-275-0625 Fax: 620-275-7908 |
Anthony L Snow, LMLP, LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1145 E Kansas Plz, Garden City, KS 67846 Phone: 620-275-0625 Fax: 620-275-7908 |
Mr. Marshall H Lewis, LMLP, LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1145 E Kansas Plz, Garden City, KS 67846 Phone: 620-275-0625 Fax: 620-275-7908 |
Monserrat Feria-vargas Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1111 E Spruce St, Garden City, KS 67846 Phone: 620-276-7689 |
Ms. Teresa Rene Sutherlin, LCP Psychologist - Group Psychotherapy Medicare: Not Enrolled in Medicare Practice Location: 531 Campus View St, Garden City, KS 67846 Phone: 620-275-0644 Fax: 620-272-0239 |
Melissa Rose Parker, LMLP Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 531 Campus View St, Garden City, KS 67846 Phone: 620-275-0644 Fax: 620-272-0239 |
News Archive
Consumer-directed health care (CDHC) - high-deductible plans often touted as the answer to spiraling health care costs - is not likely to curb health care costs, and could even worsen health outcomes by reducing patients' receipt of needed preventive care and care for chronic conditions, says a new report from The Commonwealth Fund.
Asterias Biotherapeutics, Inc. announced today that the Company has signed a Notice of Grant Award (NGA) with the California Institute of Regenerative Medicine (CIRM), effective October 1, 2014.
Type 1 diabetes, or T1D, is an autoimmune disease in which the body's immune cells -; led by inflammatory macrophages -; attack and destroy the beta cells of the pancreas that produce insulin.
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 26, 2021, to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Janssen Biotech Inc.
› Verified 9 days ago